Sicart Associates’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,100
| Closed | -$207K | – | 68 |
|
|
2023
Q2 | $207K | Sell |
5,100
-3,075
| -38% | -$125K | 0.08% | 63 |
|
|
2023
Q1 | $396K | Hold |
8,175
| – | – | 0.15% | 53 |
|
|
2022
Q4 | $312K | Hold |
8,175
| – | – | 0.11% | 63 |
|
|
2022
Q3 | $410K | Hold |
8,175
| – | – | 0.15% | 56 |
|
|
2022
Q2 | $327K | Hold |
8,175
| – | – | 0.1% | 60 |
|
|
2022
Q1 | $305K | Hold |
8,175
| – | – | 0.08% | 72 |
|
|
2021
Q4 | $328K | Hold |
8,175
| – | – | 0.09% | 78 |
|
|
2021
Q3 | $304K | Hold |
8,175
| – | – | 0.08% | 86 |
|
|
2021
Q2 | $346K | Hold |
8,175
| – | – | 0.08% | 86 |
|
|
2021
Q1 | $387K | Sell |
8,175
-25
| -0.3% | -$1.18K | 0.1% | 76 |
|
|
2020
Q4 | $500K | Hold |
8,200
| – | – | 0.12% | 73 |
|
|
2020
Q3 | $383K | Hold |
8,200
| – | – | 0.11% | 76 |
|
|
2020
Q2 | $416K | Hold |
8,200
| – | – | 0.13% | 72 |
|
|
2020
Q1 | $366K | Sell |
8,200
-525
| -6% | -$23.4K | 0.14% | 67 |
|
|
2019
Q4 | $419K | Hold |
8,725
| – | – | 0.14% | 75 |
|
|
2019
Q3 | $295K | Buy |
8,725
+550
| +7% | +$18.6K | 0.1% | 87 |
|
|
2019
Q2 | $368K | Hold |
8,175
| – | – | 0.15% | 67 |
|
|
2019
Q1 | $308K | Hold |
8,175
| – | – | 0.13% | 70 |
|
|
2018
Q4 | $281K | Hold |
8,175
| – | – | 0.14% | 72 |
|
|
2018
Q3 | $384K | Hold |
8,175
| – | – | 0.18% | 66 |
|
|
2018
Q2 | $276K | Hold |
8,175
| – | – | 0.14% | 77 |
|
|
2018
Q1 | $221K | Buy |
+8,175
| New | +$221K | 0.13% | 84 |
|
|
2017
Q1 | – | Sell |
-431,135
| Closed | -$4.7M | – | 101 |
|
|
2016
Q4 | $4.7M | Buy |
+431,135
| New | +$4.7M | 3.25% | 5 |
|